{"transactions":[{"id":4623703,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2026-09-21T22:04:37.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":4077,"price":3.2364,"value":13194.8028,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":17082,"source":{"system":"sec-edgar","filing":"0001193125-26-396892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526396892/ownership.xml","form_type":"4"}},{"id":4623702,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2026-09-21T22:04:37.000Z","date":"2026-09-17","kind":"sale","planned":false,"acquired":false,"shares":2922,"price":3.3183,"value":9696.0726,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.22 to $3.67. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":21159,"source":{"system":"sec-edgar","filing":"0001193125-26-396892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526396892/ownership.xml","form_type":"4"}},{"id":4623701,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2026-09-21T22:04:37.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":843,"price":3.774,"value":3181.482,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.60 to $4.14. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":24081,"source":{"system":"sec-edgar","filing":"0001193125-26-396892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526396892/ownership.xml","form_type":"4"}},{"id":4623700,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2026-09-21T22:04:37.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":509,"price":3.876,"value":1972.884,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c)."}],"balance_after":1924,"source":{"system":"sec-edgar","filing":"0001193125-26-396892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526396892/ownership.xml","form_type":"4"}},{"id":919703,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-04T16:32:00.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2026."}],"balance_after":8000,"derivative":{"exercise_price":6.71,"expiration_date":"2036-01-27","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-037690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526037690/ownership.xml","form_type":"4"}},{"id":919702,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2026-02-04T16:32:00.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":125,"price":4.607,"value":575.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan , in transactions that were exempt under Rule 16b-3(c)."}],"balance_after":1415,"source":{"system":"sec-edgar","filing":"0001193125-26-037690","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312526037690/ownership.xml","form_type":"4"}},{"id":967934,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11299,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025."}],"balance_after":0,"derivative":{"exercise_price":7.02,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":11299},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967933,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":11299,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025."}],"balance_after":11299,"derivative":{"exercise_price":5.44,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":11299},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967932,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":14.602,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":4499},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967931,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":4499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":4499,"derivative":{"exercise_price":5.44,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":4499},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967930,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024."}],"balance_after":0,"derivative":{"exercise_price":14.602,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":2499},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967929,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":2499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024."}],"balance_after":2499,"derivative":{"exercise_price":5.44,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":2499},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967928,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1589,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024."}],"balance_after":0,"derivative":{"exercise_price":25.4,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":1589},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967927,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1589,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024."}],"balance_after":1589,"derivative":{"exercise_price":5.44,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":1589},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967926,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6699,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on January 19, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":27.8,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":6699},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967925,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":6699,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on January 19, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023."}],"balance_after":6699,"derivative":{"exercise_price":5.44,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":6699},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967924,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2199,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":61.6,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":2199},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967923,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":2199,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":2199,"derivative":{"exercise_price":5.44,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":2199},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967922,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on December 22, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":90.2,"expiration_date":"2031-12-21","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967921,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on December 22, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":600,"derivative":{"exercise_price":5.44,"expiration_date":"2031-12-21","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967920,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":400,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967919,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":375,"derivative":{"exercise_price":5.44,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967918,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1236,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on September 3, 2020, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":86.8,"expiration_date":"2030-09-02","underlying":"Common Stock","underlying_shares":1236},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":967917,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:12:47.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1236,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on September 3, 2020, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1236,"derivative":{"exercise_price":5.44,"expiration_date":"2030-09-02","underlying":"Common Stock","underlying_shares":1236},"source":{"system":"sec-edgar","filing":"0001193125-25-321149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525321149/ownership.xml","form_type":"4"}},{"id":1013896,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2025-10-24T19:19:22.000Z","date":"2025-10-22","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The shares represent restricted stock units that were received as an award, for no consideration. Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F3","text":"The restricted stock units subject to the award will vest in full on September 15, 2026, assuming continued employment through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares represent restricted stock units that were received as an award, for no consideration. Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":23943,"source":{"system":"sec-edgar","filing":"0001193125-25-250334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525250334/ownership.xml","form_type":"4"}},{"id":1013895,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2025-10-24T19:19:22.000Z","date":"2025-06-06","kind":"purchase","planned":false,"acquired":true,"shares":125,"price":5.492,"value":686.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired under the issuer's Employee Stock Purchase Plan and therefore exempt under Rule 16b-3(c)"}],"balance_after":943,"source":{"system":"sec-edgar","filing":"0001193125-25-250334","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000119312525250334/ownership.xml","form_type":"4"}},{"id":1159600,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-05T20:40:30.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":226000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025."}],"balance_after":226000,"derivative":{"exercise_price":0.351,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":226000},"source":{"system":"sec-edgar","filing":"0000950170-25-063846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000095017025063846/ownership.xml","form_type":"4"}},{"id":1159599,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2025-05-05T20:40:30.000Z","date":"2024-06-06","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.6374,"value":1593.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"and therefore exempt under Rule 16b-3(c)"},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":13863,"source":{"system":"sec-edgar","filing":"0000950170-25-063846","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000095017025063846/ownership.xml","form_type":"4"}},{"id":1159598,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Finance and PAO"}}],"security":"Common Stock","published_at":"2025-05-05T20:40:30.000Z","date":"2024-12-16","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.4965,"value":1241.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"and therefore exempt under Rule 16b-3(c)"},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":16633,"source":{"system":"sec-edgar","filing":"0000950170-25-063846","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000095017025063846/ownership.xml","form_type":"4"}},{"id":1449496,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-24T17:17:51.000Z","date":"2024-07-23","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest on July 15, 2025."}],"balance_after":90000,"derivative":{"exercise_price":0.7301,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0000950170-24-086136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000095017024086136/ownership.xml","form_type":"4"}},{"id":1449495,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67772,"kind":"person","name":"Nemec Sarah","position":1,"cik":"0002023538","reported_name":"Nemec Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-24T17:17:51.000Z","date":"2024-07-23","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024."}],"balance_after":50000,"derivative":{"exercise_price":0.7301,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-086136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023538/000095017024086136/ownership.xml","form_type":"4"}}]}